09997 KANGJI MEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 7.92X | Oper Margin | 70.1% |
---|---|---|---|
LT Debt/Equity | 0.0% | Net Margin | 57.7% |
Total Debt/Equity | 0.1% | Return on Equity | 22.1% |
Price/Book | 3.81X | Return on Assets | 19.9% |
(HKD 8.820) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 618.36 | 555.53 | 536.76 | 558.70 | 297.05 |
---|---|---|---|---|---|
Net Profit Growth (%) | +11.3 | +3.5 | -3.9 | +88.1 | +28.7 |
Earnings Per Share (HKD) | 0.526 | 0.475 | 0.444 | 0.456 | 0.312 |
Earnings Per Share Growth (%) | +10.8 | +6.9 | -2.6 | +46.3 | +100.0 |
Dividend Per Share (HKD) | 0.261 | 1.539 | 0.205 | 0.172 | 0.044 |
P/E* (X) | 16.77 | 18.58 | 19.85 | 19.33 | 28.29 |
Yield (%) | 2.96 | 17.44 | 2.32 | 1.95 | 0.50 |
Dividend Share (%) | 49.69 | 324.05 | 46.09 | 37.76 | 14.11 |
Book NAV (HKD) | 2.313 | 3.306 | 3.102 | 3.201 | 2.783 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 496.555 | 458.413 | +8.3 | 403.589 |
Operating Result | 344.418 | 333.601 | +3.2 | 271.282 |
Associates | -19.542 | -5.868 | +233.0 | 0 |
Profit Before Taxation | 324.876 | 327.733 | -0.9 | 271.282 |
Taxation | 59.116 | 52.047 | +13.6 | 41.985 |
Profit /( Loss) After Taxation | 265.76 | 275.686 | -3.6 | 229.297 |
Minority Interests | 0 | -10.161 | -100.0 | -26.164 |
Net Profit | 265.76 | 285.847 | -7.0 | 255.461 |
Earnings Per Share () | 0.2472 | 0.2622 | -5.7 | 0.2356 |
Announcement Date | 2025-08-28 | 2024-08-20 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25